SCHEMBL6000699

SCHEMBL6000699

CN(Cc1nc(-c2ccc(NCCc3ccc(C4CCCCC4)cc3)cc2)cs1)S(=O)(=O)c1cccc(C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
STAT3 P40763 5/20 0.39
PTPRB P23467 3/20 0.39
STAT1 P42224 1/20 0.39
STAT5B P51692 1/20 0.39
PTPRF P10586 1/20 0.38
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN11 Q06124 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
PTGER2 P43116 1/20 0.37
AKR1C3 P42330 2/20 0.37
HSD17B10 Q99714 1/20 0.37
ADRB3 P13945 1/20 0.36
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999078 0.91 AVPR1B (0.42) MEN1POLBKMT2ASTAT3STAT1
SCHEMBL6000702 0.87 AKR1C3 (0.47) ALDH1A1MEN1POLBKMT2AAKR1C3
SCHEMBL6000694 0.87 STAT3 (0.46) ALDH1A1MEN1POLBKMT2ASTAT3
SCHEMBL6000055 0.84 NPC1 (0.39) ALDH1A1MEN1POLBKMT2ASTAT3
SCHEMBL6000624 0.84 TRPM8 (0.40) ALDH1A1MEN1POLBKMT2ASTAT3
SCHEMBL5999737 0.83 RAB9A (0.40) ALDH1A1MEN1POLBKMT2ASTAT3
SCHEMBL5999893 0.83 RAB9A (0.39) ALDH1A1MEN1POLBKMT2ANPC1
SCHEMBL6001062 0.83 RAB9A (0.39) ALDH1A1MEN1POLBKMT2ASTAT3
SCHEMBL6001067 0.81 RAB9A (0.42) ALDH1A1MEN1POLBKMT2ANPC1
SCHEMBL5999224 0.81 NPC1 (0.41) ALDH1A1MEN1POLBKMT2APTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 ALDH1A1 1733/4885MEN1 4550/4885POLB 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.